Recruiting

Telemedicine Care

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04988009

Conditions

Central Nervous System Neoplasm

Leptomeningeal Neoplasm

Metastatic Malignant Neoplasm in the Brain

Primary Brain Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Electronic Health Record Review

Survey Administration

Study Details

Brief summary:

This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.

Conditions

Central Nervous System Neoplasm

Leptomeningeal Neoplasm

Metastatic Malignant Neoplasm in the Brain

Primary Brain Neoplasm

Study ID

NCT04988009

Start date

Aug 20, 2020

Status verified date

Mar, 2026

Completion date

Dec 31, 2026

Anticipated

Primary completion date

Dec 31, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease
  • Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be

  • An in-person visit
  • A telemedicine appointment

Exclusion Criteria:

  • Encounter occurred with the assistance of official language translation support
  • Patients with telephone encounters (without interactive video)
  • New patient or consult visits
  • Neither patient nor caregiver present during the visit are available or able to answer survey questions

Study Design

Enrollment

200 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational (survey, medical chart review)

Patients complete a survey related to their perceived quality of care via telephone and have their medical chart reviewed prospectively.

Interventions

Electronic Health Record Review

Review of medical chart

Survey Administration

Complete survey

Primary outcome measure

  • Survey response to question 6 of the quality of care survey ("I felt I received good medical care during this encounter") [ Time Frame: through study completion, an average of 1 year ]

Central Contacts and Locations

Central contacts

Barbara J O'Brien, MD

713-794-4380bjobrien@mdanderson.org

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Barbara J O'Brien, MD

713-794-4380bjobrien@mdanderson.org

Principal Investigator:

Barbara J O'Brien, MD

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Mar 5, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-03-05.